Atlas Trials

Prestige Biopharma Limited

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Prestige Biopharma Limited

RecordFirmDate
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer (NCT05141149)Prestige Biopharma Limited2023-06-05
To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects (NCT05108259)Prestige Biopharma Limited2022-03-30
A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients (NCT03390686)Prestige Biopharma Limited2019-11-15
A Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU-Herceptin® and US-Herceptin® in Healthy Male Subjects (NCT03776240)Prestige Biopharma Limited2019-04-01
To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects (NCT03390673)Prestige Biopharma Limited2018-09-19
A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients (NCT03013504)Prestige Biopharma Limited2018-02-19

Track Prestige Biopharma Limited automatically

Every clearance here is in the API, with alerts when new ones post.